TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
22 hedge funds and large institutions have $1.76M invested in Titan Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less capital invested
Capital invested by funds: $2.1M → $1.76M (-$343K)
Holders
22
Holding in Top 10
–
Calls
$53K
Puts
–
Top Buyers
| 1 | +$75.3K | |
| 2 | +$58.5K | |
| 3 | +$41.8K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.5K |
| 5 |
Bank of New York Mellon
New York
|
+$4.18K |
Top Sellers
| 1 | -$41.8K | |
| 2 | -$18K | |
| 3 | -$16K | |
| 4 |
Morgan Stanley
New York
|
-$4.18K |
| 5 |
SRAM
Stone Ridge Asset Management
New York
|
-$4.18K |